Ifenprodil
| Clinical data | |
|---|---|
| Trade names | Cerocral, Dilvax, Vadilex |
| Other names | NP-120; NP 120; NP120; RC 61-91 |
| Drug class | Cerebral vasodilators; NMDA receptor antagonists |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.041.341 |
| Chemical and physical data | |
| Formula | C21H27NO2 |
| Molar mass | 325.452 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Ifenprodil, sold under the brand names Cerocral, Dilvax, and Vadilex, is a cerebral vasodilator that has been marketed in some countries, including in Japan, Hong Kong, and France. It is currently under development for treatment of a variety of additional indications.
Ifenprodil has multiple known pharmacological actions. It is an inhibitor of the NMDA receptor, specifically of NMDA receptors containing GluN1 and GluN2B subunits, the "ifenprodil binding site". Additionally, ifenprodil inhibits GIRK channels and interacts with α1-adrenergic, serotonin, and sigma receptors.
Chemically, ifenprodil is a substituted phenethylamine and β-hydroxyamphetamine derivative. It is used pharmaceutically as the tartrate salt.